Truist Securities confirmed its positive stance on Iovance Biotherapeutics (NASDAQ:IOVA) shares, maintaining a Buy rating and a price target of $25.00. With the stock currently trading at $6.07, this ...
Truist Securities upgraded Pacira Pharmaceuticals (NASDAQ:PCRX) stock rating from Hold to Buy, significantly raising the price target to $25.00 from the previous $8.00. The stock, currently trading at ...
Analysts at Truist Financial assumed coverage on shares of Tronox (NYSE:TROX – Get Free Report) in a research note issued to ...
"I think the market can live with where rates are now, as long as the 10-year rate is stable," said Keith Lerner, co-chief investment officer at Truist Advisory Services, in a call following the Fed ...
As rights-backed securitization deals grow more prevalent in the music industry, Influence Media Partners has obtained $360 ...
Meta's earnings call is today at 5 pm ET. META stock heads into the report up 15% YTD. Analysts are focused on AI ...
Wednesday afternoon, a massive police presence was observed by Chopper 9 Skyzoom outside a bank in Ballantyne.
Influence Media Partners has confirmed that it has secured approximately $360 million in debt financing through an inaugural ...